5 Insightful Analyst Questions From GE HealthCare’s Q1 Earnings Call
GE HealthCare’s first quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, buoyed by robust demand in imaging and strong U.S. market performance. CEO Peter Arduini credited “record double-digit orders growth as a standalone company” to heightened customer focus on imaging solutions for cardiology and oncology, as well as share gains in key markets. The company noted broad-based organic revenue growth across all segments, with particular momentum in product innovation and new contract wins. In the words of CFO Jay Saccaro, “organic orders growth was robust, up 10% year-over-year, the highest since our spend,” underscoring healthy market demand and a record backlog.
Is now the time to buy GEHC? Find out in our full research report (it’s free).
GE HealthCare (GEHC) Q1 CY2025 Highlights:
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions GE HealthCare’s Q1 Earnings Call
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) the pace and effectiveness of tariff mitigation strategies, (2) the ramp-up and adoption of new products like Flyrcado and Revolution Vibe, and (3) trends in order growth and backlog conversion, especially as market conditions evolve in China and key international markets. Progress on these fronts will help determine GE HealthCare’s ability to sustain revenue growth and margin improvement.
GE HealthCare currently trades at $76.15, up from $68.09 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free) .
Our Favorite Stocks Right Now
Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week . This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today .